Physician profile
Matthew Bocchese
NPI 1649762840
$1,208.77
in general payments reported to CMS, 2019-2025
17 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $277 · 2023: $336 · 2024: $279 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.92 |
| Education | $131.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $401.04 | 2022-2024 | Ensite, Assurity |
| Novartis Pharmaceuticals Corporation | $125.23 | 2025 | |
| Merck Sharp & Dohme LLC | $115.95 | 2023-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $100.64 | 2023-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $90.14 | 2024-2025 | Accolade Sr, General - Therapies |
| Actelion Pharmaceuticals US, INC. | $75.12 | 2024-2025 | Uptravi |
| Abiomed | $74.94 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.70 | 2022-2025 | Lifevest |
| Pfizer INC. | $29.78 | 2025 | |
| Biosense Webster, INC. | $28.42 | 2023 | Na, Soundstar, Nuvision Ice Catheter |
| Kiniksa Pharmaceuticals International, Plc | $23.95 | 2024 | Arcalyst |
| Livanova USA, INC. | $21.78 | 2024 | Protekduo |
| Scpharmaceuticals INC. | $18.55 | 2025 | |
| Alnylam Pharmaceuticals INC. | $18.40 | 2025 | Onpattro |
| Amgen INC. | $16.42 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.19 | 2024 | Farxiga |
| Terumo Medical Corporation | $13.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bocchese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.